Astellas and Pfizer Announce Amendment to Clinical Research Protocol for Phase 3 PROSPER Trial of enzalutamide Read more
Sanofi and Regeneron Announce Positive Results from First Dedicated Studies Evaluating Praluent Read more
Numerate and Takeda Enter Agreement to Generate Novel Clinical Candidates Using AI-Driven Drug Discovery Read more